Immunglobulin M Enriched Intra Venous Immunoglobulin (IVIG) Therapy in Adult Respiratory Distress Syndrom (ARDS) Patients
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
57 patients with Adult Respiratory Distress Syndrome (ARDS) requiring Extracorporeal membrane
oxygenation (ECMO) therapy were analyzed retrospectively. 28 patients had received
immunglobulin M-enriched immunoglobulin therapy (IVIG); 29 patients did not receive IVIG
therapy.
These patients were analyzed regarding length of stay in intensive care unit (LOS ICU),
length of stay (LOS) in hospital and regarding mortality.
Details
Lead Sponsor:
University Hospital Tuebingen
Collaborators:
Institute for Clinical Epidemiology and applied Biometry, University Tuebingen Universität Tübingen